NCT07821333: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II-III
- State
- Under way
- Phase
- Phase 2
- People
- 45 taking part
- Started
- 1 Jan 2022
- Primary completion
- 1 Jan 2027
- Arms
- FOLFOXIRI
- Results
- None posted
- 1 Jan 2022: Trial started
- 15 Sep 2026: Trial registered